Entities / Company
Kamada Ltd..
pharmaceutical company
- Reports this week
- 1
- Active events
- 1
- Connections
- 16
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
Gone quiet
No new reports in 90+ days-
MarketBeat aggregated data and Benchmark provided research reports on Kamada Ltd.'s stock performance.Some support1 report
-
Qatar's market indices reached new highs on August 14, 2025, coinciding with updates on Atreyu Capital Markets operating in Israel and Kamada being a top screener pick.Well supported3 reports1 development inside
-
Kamada Ltd. operates plasma collection centers in multiple US cities and received FDA approval for its supplement.Some support3 reports
-
Kamada Ltd.'s CEO, Amir London, was reported to be participating in investor conferences in September 2025, with articles dated from Hoboken, NJ.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Kamada Ltd. this week
News at the entities that move Kamada Ltd. most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Kamada Ltd.
-
Benchmark Mentioned togetherMarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.Moves Kamada Ltd.
-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Kamada Ltd.
-
Houston Shared contextOntario company turns woody biomass into coal replacement while TCEQ regulates site acquisition in Houston.Moves Kamada Ltd.
-
Nasdaq Shared contextAppLovin stock is traded on Nasdaq, and both AppLovin and Trade Desk operate in the competitive digital advertising technology landscape.Moves Kamada Ltd.
Connections
The 5 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA formally regulates Kamada Ltd., granting approval for its products and operations.
-
MarketBeat Mentioned together
MarketBeat aggregates and tracks data regarding Kamada Ltd.'s stock performance.
-
Benchmark Mentioned together
Benchmark publishes research reports concerning Kamada Ltd.
-
Houston Shared context
Kamada Ltd. operates plasma collection centers within the city of Houston.
-
Nasdaq Shared context
Kamada Ltd. trades on the Nasdaq stock exchange.
History
Events by the month they beganSeptember 2026
1 eventJune 2026
4 events- MarketBeat aggregated data and Benchmark provided research reports on Kamada Ltd.'s stock performance.
- Qatar's market indices reached new highs on August 14, 2025, coinciding with updates on Atreyu Capital Markets operating in Israel and Kamada being a top screener pick.
- Kamada Ltd. operates plasma collection centers in multiple US cities and received FDA approval for its supplement.
- Kamada Ltd.'s CEO, Amir London, was reported to be participating in investor conferences in September 2025, with articles dated from Hoboken, NJ.